"Shades of gray" in cardiac magnetic resonance images of infarcted myocardium: Can they tell us what we'd like them to?

Circulation

Volumn 114, Issue 1, 2006, Pages 8-10

  Klocke, Francis J ^a   Wu, Edwin ^a   Lee, Daniel C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; EDITORIAL; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HUMAN; KAPLAN MEIER METHOD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; NOTE; RISK ASSESSMENT; SCINTISCANNING;

DIAGNOSTIC AGENT; GADOLINIUM; RADIOISOTOPE;

DEATH, SUDDEN, CARDIAC; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; RADIOISOTOPES; RISK ASSESSMENT;

EID: 33746223017     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.636456     Document Type: Editorial

References (12)

1. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97:1514-1521.
2. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215-223.
3. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45:1104-1108.
4. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, for the MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol. 2006;47:98-107.
5. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds GH, Stevenson WG, Kwong R. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32-39.
6. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
7. Wagner A, Mahrholdt H, Thomson L, Hager S, Meinhardt G, Rehwald W, Parker M, Sechtem U, Kim RJ, Judd RM. Effects of time, dose and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol. 2006;47:2027-2033.
8. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318-3326.
9. Azevedo C, Lima JA, Silva C, Bluemke DA, Weiss RG, Gerstenblith G, Thiemann DR, Halperin H, Steinberg T, Nazarian S, Berger R, Marban E, Wu KC. Tissue heterogeneity by contrast-enhanced MRI as a marker of risk for sudden cardiac death in ischemic cardiomyopathy (abstract). Circulation. 2004;110(suppl III):III-644.
10. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JAC, Halperin HR. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005;112:2821-2825.
11. 99mTc-sestamibi imaging predicts subsequent mortality. Circulation. 1995;92:334-341.
12. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S, for the CORE Study Investigators. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30-36.